Trial Condition(s):

Angiocardiography

The safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST) (TRUST)

Bayer Identifier:

15454

ClinicalTrials.gov Identifier:

NCT01206257

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study is to collect the information of Ultravist® in the patients indicated for the coronary angiography or PCI, like rate of ADR in patients, the dose for different indications, image quality to prove Ultravist the good safety and effectivity

Inclusion Criteria
- Female and male patients who receive Ultravist® for coronary angiography or PCI can be included in the study
Exclusion Criteria
- Patients who are or are suspected in pregnancy or nursery
 - Patients with the contraindications for Ultravist
- Patients with the contraindications for cardiac catheterization

Trial Summary

Enrollment Goal
17513
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Ultravist (Iopromide, BAY86-4877)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, China

Status
Completed
 

Trial Design